Owners, management and financials
CVR: 33874057
Previous names: REMA BUTIKSEJENDOMME A/S, REBUS Handelsejendomme A/S
DKK 44,094,000
Gross profit
Net result: DKK 44,965,000
REBUS Handelseiendom AS (100%)
CVR · view owners
Jørn Egil Andreassen
Board: Thomas Gerhard Dahle (chair) and 3 members
CVR · view management
Active
Founded 23 August 2011
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: REBUS Medinvest A/S
CVR · 18/09/2024
View the full event history
REBUS Medinvest A/S is a Danish company of the type Aktieselskab based in Horsens, founded in 2011. The company is registered under the industry Udlejning af erhvervsejendomme. The company was previously named REBUS Handelsejendomme A/S and REMA BUTIKSEJENDOMME A/S. The management consists of Jørn Egil Andreassen. The board consists of Thomas Gerhard Dahle (chair), Jørn Egil Andreassen, Ketil Jøssund and Trond Fredrik Mellingsæter. The company is owned by REBUS Handelseiendom AS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 44,094,000 and a net result of DKK 44,965,000 compared with DKK 57,599,000 the year before. Equity in the 2025 report amounted to DKK 612,451,000.
Source: annual report 2025, Danish Business Authority
The financial health of REBUS Medinvest A/S appears strong, particularly highlighted by its significant equity position, which increased from 459.5 million DKK in 2021 to 612.5 million DKK in 2025. Gross profit has shown a steady upward trend, rising from 34.7 million DKK in 2021 to 44.1 million DKK in 2025, despite a notable dip in profit to -3.1 million DKK in 2023. The company has rebounded well, achieving a profit of 44.97 million DKK in 2025. While revenue figures are not disclosed, the consistent growth in gross profit suggests a solid operational performance within the commercial real estate rental sector. Overall, REBUS Medinvest A/S is well-positioned in its industry, with strong equity and improving profitability trends.
AI-generated summary · Generated 16/08/2026
Selskabets formål er er investering i fast ejendom samt hermed beslægtet virksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 44.1M | 45M | 1.1B | 612.5M | 0 | |
| 202401/01/2024 – 31/12/2024 | 37.3M | 57.6M | 959.1M | 567.5M | 0 | |
| 202301/01/2023 – 31/12/2023 | 36.3M | -3.1M | 903.2M | 509.9M | - | |
| 202201/01/2022 – 31/12/2022 | 35.2M | 53.6M | 919.6M | 513M | - | |
| 202101/01/2021 – 31/12/2021 | 34.7M | 36.1M | 893.7M | 459.5M | - | |
| 202001/01/2020 – 31/12/2020 | 64.9M | 29.4M | 599.9M | 355M | - | |
| 201901/01/2019 – 31/12/2019 | 56.6M | 29.8M | 928.6M | 322.6M | 1 | |
| 201801/01/2018 – 31/12/2018 | 38.9M | 18.5M | 829.1M | 292.8M | 1 | |
| 201701/01/2017 – 31/12/2017 | 40.5M | 21.3M | 693.8M | 274.2M | 1 | |
| 201601/01/2016 – 31/12/2016 | 26.2M | 12.2M | 582M | 252.9M | - | |
| 201501/01/2015 – 31/12/2015 | - | - | - | 102M | - | |
| 201401/01/2014 – 31/12/2014 | 17.2M | 7.4M | 425.1M | 214.6M | - | |
| 201301/01/2013 – 31/12/2013 | 11.8M | 5.1M | 317.4M | 157.2M | - | |
| 201201/01/2012 – 31/12/2012 | 6M | 2M | 158.1M | 82M | - |
Compared to 18.834 companies in Udlejning af erhvervsejendomme
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
27 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of REBUS Medinvest A/S is 33874057.
REBUS Medinvest A/S is owned by REBUS Handelseiendom AS.
The management of REBUS Medinvest A/S consists of Jørn Egil Andreassen.
The board of REBUS Medinvest A/S consists of Thomas Gerhard Dahle, Jørn Egil Andreassen and Ketil Jøssund, with Thomas Gerhard Dahle as chair.
In 2025, REBUS Medinvest A/S reported a gross profit of DKK 44,094,000.
REBUS Medinvest A/S had an average of 0 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
REBUS Medinvest A/S has published its annual report for 2025. Gross profit came to DKK 44,094,000, and the net result was DKK 44,965,000.
REBUS Medinvest A/S has published its annual report for 2024. Gross profit came to DKK 37,309,000, and the net result was DKK 57,599,000.
On September 18, 2024, the company changed its name from REBUS Handelsejendomme A/S to REBUS Medinvest A/S.
As of August 16, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of REBUS Medinvest A/S.
As of August 16, 2024, EY Godkendt Revisionspartnerselskab has stepped down as auditor of REBUS Medinvest A/S.
REBUS Medinvest A/S has published its annual report for 2023. Gross profit came to DKK 36,276,000, and the net result was DKK -3,138,000.
As of November 15, 2023, is registered as an owner of REBUS Medinvest A/S with an ownership share of 100%.
REBUS Medinvest A/S has published its annual report for 2022. Gross profit came to DKK 35,204,000, and the net result was DKK 53,557,000.
As of January 9, 2023, Trond Fredrik Mellingsæter has joined the board of directors of REBUS Medinvest A/S.
As of January 9, 2023, Thomas Gerhard Dahle has joined the board of directors of REBUS Medinvest A/S.
As of January 9, 2023, Ingolv Høyland has left the board of directors of REBUS Medinvest A/S.
REBUS Medinvest A/S has published its annual report for 2021. Gross profit came to DKK 34,739,000, and the net result was DKK 36,064,000.
On March 17, 2022, the company changed its name from REMA BUTIKSEJENDOMME A/S to REBUS Handelsejendomme A/S.
REBUS Medinvest A/S has published its annual report for 2020. Gross profit came to DKK 64,927,000, and the net result was DKK 29,423,000.
As of April 8, 2021, Ketil Jøssund has joined the board of directors of REBUS Medinvest A/S.
As of April 8, 2021, Jørn Egil Andreassen has joined the board of directors of REBUS Medinvest A/S.
As of April 8, 2021, Ingolv Høyland has joined the board of directors of REBUS Medinvest A/S.
As of April 8, 2021, Torben Lennart Sørensen has left the board of directors of REBUS Medinvest A/S.
As of April 8, 2021, Henrik Burkal has left the board of directors of REBUS Medinvest A/S.
As of April 8, 2021, Anders René Jensen has left the board of directors of REBUS Medinvest A/S.
As of April 8, 2021, Jørn Egil Andreassen is registered as adm. dir. of REBUS Medinvest A/S.
As of April 8, 2021, Jan Kvolbæk Poulsen has stepped down as adm. dir. of REBUS Medinvest A/S.
REBUS Medinvest A/S has published its annual report for 2019. Gross profit came to DKK 56,551,000, and the net result was DKK 29,811,000.
REBUS Medinvest A/S has published its annual report for 2018. Gross profit came to DKK 38,892,016, and the net result was DKK 18,530,640.
REBUS Medinvest A/S has published its annual report for 2017. Gross profit came to DKK 40,512,814, and the net result was DKK 21,290,285.
REBUS Medinvest A/S has published its annual report for 2016. Gross profit came to DKK 26,217,575, and the net result was DKK 12,214,763.
As of November 29, 2016, Torben Lennart Sørensen has joined the board of directors of REBUS Medinvest A/S.
As of November 29, 2016, Mads Nysted has left the board of directors of REBUS Medinvest A/S.
As of November 29, 2016, Lars Retoft has left the board of directors of REBUS Medinvest A/S.
As of November 29, 2016, Torben Lennart Sørensen has stepped down as director of REBUS Medinvest A/S.
As of August 10, 2016, EY Godkendt Revisionspartnerselskab has been appointed auditor of REBUS Medinvest A/S.
As of August 10, 2016, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of REBUS Medinvest A/S.
REBUS Medinvest A/S has published its annual report for 2015.
As of November 30, 2015, Stephan Sørensen has stepped down as director of REBUS Medinvest A/S.
As of September 30, 2015, Stephan Sørensen is registered as director of REBUS Medinvest A/S.
As of September 30, 2015, Jan Kvolbæk Poulsen is registered as adm. dir. of REBUS Medinvest A/S.
REBUS Medinvest A/S has published its annual report for 2014. Gross profit came to DKK 17,225,974, and the net result was DKK 7,416,605.
As of October 7, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of REBUS Medinvest A/S.
As of October 7, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of REBUS Medinvest A/S.
REBUS Medinvest A/S has published its annual report for 2013. Gross profit came to DKK 11,750,313, and the net result was DKK 5,143,495.
REBUS Medinvest A/S has published its annual report for 2012. Gross profit came to DKK 6,007,884, and the net result was DKK 1,990,484.
As of August 23, 2011, A/S PSE NR. 2857 has been appointed auditor of REBUS Medinvest A/S.
As of August 23, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of REBUS Medinvest A/S.
As of August 23, 2011, A/S PSE NR. 2857 has stepped down as auditor of REBUS Medinvest A/S.
As of August 23, 2011, Henrik Burkal has joined the board of directors of REBUS Medinvest A/S.
As of August 23, 2011, Anders René Jensen has joined the board of directors of REBUS Medinvest A/S.
As of August 23, 2011, Mads Nysted has joined the board of directors of REBUS Medinvest A/S.
As of August 23, 2011, Lars Retoft has joined the board of directors of REBUS Medinvest A/S.
As of August 23, 2011, Torben Lennart Sørensen is registered as director of REBUS Medinvest A/S.
REBUS Medinvest A/S was founded on August 23, 2011.
Companies in the same industry and area
CVR 30968956
CVR 32964346
CVR 31724236
CVR 32617158
CVR 29352925
